Importance of Patient Capital in Life Sciences
TSX Venture Exchange has a strong history of helping early-stage health and life sciences companies raise patient capital for research and development purposes.
TSX Venture Exchange has a strong history of helping early-stage health and life sciences companies raise patient capital for research and development purposes.
At the MedCity INVEST conference this week, a panel discussion highlighted the benefits of going public in Canada as an alternative path for young growth stage companies to raise capital.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
TSX Venture Exchange has a strong history of helping early stage health and life sciences companies raise patient capital for research and development purposes.
Register for MedCity INVEST at the Ritz Carlton in Chicago and be part of the conversation on healthcare investment trends. Attendees will also be able to take part in networking opportunities and hear health tech, medtech and pharma tech startups pitch to investors.